ACB Long Call Strategy
ACB (Aurora Cannabis Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach.
ACB (Aurora Cannabis Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $227.9M, a beta of 1.34 versus the broader market, a 52-week range of 2.56-6.665, average daily share volume of 1.3M, a public-listing history dating back to 2014, approximately 1K full-time employees. These structural characteristics shape how ACB stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.34 indicates ACB has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on ACB?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
ACB snapshot
As of August 14, 2026, spot at $3.67, ATM IV 16.30%, IV rank 1.63%, expected move 4.67%. The long call on ACB below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on ACB specifically: ACB IV at 16.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a ACB long call, with a market-implied 1-standard-deviation move of approximately 4.67% (roughly $0.17 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ACB expiries trade a higher absolute premium for lower per-day decay. Position sizing on ACB should anchor to the underlying notional of $3.67 per share and to the trader's directional view on ACB stock.
ACB long call setup
The ACB long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ACB at $3.67 on that close, the first option leg uses a $3.67 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ACB chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ACB shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $3.67 | N/A |
ACB long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ACB long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ACB. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ACB
Long calls on ACB express a bullish thesis with defined risk; traders use them ahead of ACB catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ACB thesis for this long call
The market-implied 1-standard-deviation range for ACB extends from approximately $3.50 on the downside to $3.84 on the upside. A ACB long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ACB IV rank near 1.63% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ACB at 16.30%. As a Healthcare name, ACB options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ACB-specific events.
ACB long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ACB positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ACB alongside the broader basket even when ACB-specific fundamentals are unchanged. Long-premium structures like a long call on ACB are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ACB chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ACB?
- A long call on ACB is the long call strategy applied to ACB (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ACB stock at $3.67 on the most recent close, the strikes shown on this page are snapped to the nearest listed ACB chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ACB long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ACB long call priced from the end-of-day chain at a 30-day expiry (ATM IV 16.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ACB long call?
- The breakeven for the ACB long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ACB market-implied 1-standard-deviation expected move in the same options snapshot is approximately 4.67%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ACB?
- Long calls on ACB express a bullish thesis with defined risk; traders use them ahead of ACB catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ACB implied volatility affect this long call?
- ACB ATM IV is at 16.30% with IV rank near 1.63%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.